Results 101 to 110 of about 14,451 (146)

Hormonal Contraceptive Use and Affective Disorders: An Updated Review. [PDF]

Open Access J Contracept
Mengelkoch S, Afshar K, Slavich GM.
europepmc   +1 more source

How Hormonal Balance Changes Lives in Women with Psoriasis. [PDF]

J Clin Med
Cassalia F, Lunardon A, Frattin G, Danese A, Caroppo F, Fortina AB.   +5 more
europepmc   +1 more source

Comparison of Combined Oral Contraceptives and a Transdermal Estrogen Patch With Oral Progesterone: Treatment of Abnormal Uterine Bleeding in Adolescents. [PDF]

Cureus
Ulukapi HB, Simsek E.
europepmc   +1 more source

Treatment and fertility outcomes of moss-like endometriosis with hemorrhagic ascites: A case report. [PDF]

Medicine (Baltimore)
Xu F, Gao Y, He F, Zhao M, Li A.
europepmc   +1 more source

Pharmacological and Non-Pharmacological Interventions for Polycystic Ovary Syndrome (PCOS) in Indian Women: A Systematic Review and Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
Maan P, Gautam R, Vasudevan S, Menon GR, Arora A, Nair A, Jabbar PK, Arora T.   +7 more
europepmc   +1 more source

Association between the use of oral contraceptives and the occurrence of systemic hypertension: A systematic review with statistical comparison between randomized clinical trial interventions. [PDF]

Eur J Obstet Gynecol Reprod Biol X
de Souza IS, Laporta GZ, Zangirolami-Raimundo J, Sorpreso ICE, Silva Dos Santos HCL, Soares Júnior JM, Raimundo RD.   +6 more
europepmc   +1 more source

Factors Associated With Uterine Endometrial Hyperplasia and Pyometra in Wild Canids: Implications for Fertility [PDF]

Asa, C S, Bauman, K L, Boutelle, S, Camilo, G R, Chile, Denver Zoo, Devery, S, Moresco, A, St Louis Zoo, Zordan, M   +9 more
core  

Oral contraception can decrease the pituitary capacity to release gonadotrophins in response to synthetic LH-releasing-hormone [PDF]

Archiv f�r Gyn�kologie, 1973
The amounts of luteinizing hormone (LH) and follicle stimulating hormone (FSH) released in response to the intravenous administration of 12.5, 25, and 100μg of LH-Releasing Hormone (LH-RH) were found to be severely impeded in 4 out of 5 women who had been taking oral contraceptives for periods ranging from 12 to 36 months.
J. S. E. Dericks-Tan, J. S. E. Dericks-Tan, Jürgensen O, Jürgensen O, Taubert Hd, Taubert Hd, C. Robyn, C. Robyn, H. Schöndorf, H. Schöndorf   +9 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

A Synthetic Steroid (R2323) as a Once-A-Week Oral Contraceptive

Fertility and Sterility, 1979
Five milligrams of the steroid R2323 (13 beta-ethyl-17 alpha-ethynyl-17-hydroxygona-4,9,11-trien-3-one (R2323) were administered orally once weekly to 28 subjects for a total of 138 treatment cycles. No pregnancies occurred. The predominant side effects were irregular vaginal bleeding, headache, weight gain, and acne.
Celso-Ramon Garcia, Carol Busacca, Sami S. David, George R. Huggins   +3 more
openaire   +3 more sources

The estrogenic activity of synthetic progestins used in oral contraceptives

Cancer, 1993
AbstractBackground. Oral contraceptives (OC) contain an orally active estrogen in combination with an orally active synthetic progestin derived from 19‐nortestosterone. OC have had an enormous positive impact on public health for the past three decades, and in the main, there has been a remarkably low incidence of troublesome side effects.
William H. Catherino, Virgil Craig Jordan, Parker Cj, Meei Huey Jeng   +3 more
openaire   +3 more sources